These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 12538652

  • 21. Cross-talk between the p42/p44 MAP kinase and Smad pathways in transforming growth factor beta 1-induced furin gene transactivation.
    Blanchette F, Rivard N, Rudd P, Grondin F, Attisano L, Dubois CM.
    J Biol Chem; 2001 Sep 07; 276(36):33986-94. PubMed ID: 11448947
    [Abstract] [Full Text] [Related]

  • 22. Requirement of mitogen-activated protein kinase kinase 3 (MKK3) for activation of p38alpha and p38delta MAPK isoforms by TGF-beta 1 in murine mesangial cells.
    Wang L, Ma R, Flavell RA, Choi ME.
    J Biol Chem; 2002 Dec 06; 277(49):47257-62. PubMed ID: 12374793
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells.
    Rhyu DY, Yang Y, Ha H, Lee GT, Song JS, Uh ST, Lee HB.
    J Am Soc Nephrol; 2005 Mar 06; 16(3):667-75. PubMed ID: 15677311
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The mitogen-activated protein (MAP) kinase p38 and its upstream activator MAP kinase kinase 6 are involved in the activation of signal transducer and activator of transcription by hyperosmolarity.
    Bode JG, Gatsios P, Ludwig S, Rapp UR, Häussinger D, Heinrich PC, Graeve L.
    J Biol Chem; 1999 Oct 15; 274(42):30222-7. PubMed ID: 10514514
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Rac1-MKK3-p38-MAPKAPK2 pathway promotes urokinase plasminogen activator mRNA stability in invasive breast cancer cells.
    Han Q, Leng J, Bian D, Mahanivong C, Carpenter KA, Pan ZK, Han J, Huang S.
    J Biol Chem; 2002 Dec 13; 277(50):48379-85. PubMed ID: 12377770
    [Abstract] [Full Text] [Related]

  • 30. MKK6/3 and p38 MAPK pathway activation is not necessary for insulin-induced glucose uptake but regulates glucose transporter expression.
    Fujishiro M, Gotoh Y, Katagiri H, Sakoda H, Ogihara T, Anai M, Onishi Y, Ono H, Funaki M, Inukai K, Fukushima Y, Kikuchi M, Oka Y, Asano T.
    J Biol Chem; 2001 Jun 08; 276(23):19800-6. PubMed ID: 11279172
    [Abstract] [Full Text] [Related]

  • 31. Smad2 mediates Erk1/2 activation by TGF-beta1 in suspended, but not in adherent, gastric carcinoma cells.
    Lee MS, Ko SG, Kim HP, Kim YB, Lee SY, Kim SG, Jong HS, Kim TY, Lee JW, Bang YJ.
    Int J Oncol; 2004 May 08; 24(5):1229-34. PubMed ID: 15067346
    [Abstract] [Full Text] [Related]

  • 32. The p38 MAPK inhibitor, PD169316, inhibits transforming growth factor beta-induced Smad signaling in human ovarian cancer cells.
    Fu Y, O'Connor LM, Shepherd TG, Nachtigal MW.
    Biochem Biophys Res Commun; 2003 Oct 17; 310(2):391-7. PubMed ID: 14521923
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. alpha B-crystallin gene induction and phosphorylation by MKK6-activated p38. A potential role for alpha B-crystallin as a target of the p38 branch of the cardiac stress response.
    Hoover HE, Thuerauf DJ, Martindale JJ, Glembotski CC.
    J Biol Chem; 2000 Aug 04; 275(31):23825-33. PubMed ID: 10816593
    [Abstract] [Full Text] [Related]

  • 35. The MKK6/p38 mitogen-activated protein kinase pathway is capable of inducing SOCS3 gene expression and inhibits IL-6-induced transcription.
    Bode JG, Ludwig S, Freitas CA, Schaper F, Ruhl M, Melmed S, Heinrich PC, Häussinger D.
    Biol Chem; 2001 Oct 04; 382(10):1447-53. PubMed ID: 11727828
    [Abstract] [Full Text] [Related]

  • 36. Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542.
    Laping NJ, Grygielko E, Mathur A, Butter S, Bomberger J, Tweed C, Martin W, Fornwald J, Lehr R, Harling J, Gaster L, Callahan JF, Olson BA.
    Mol Pharmacol; 2002 Jul 04; 62(1):58-64. PubMed ID: 12065755
    [Abstract] [Full Text] [Related]

  • 37. Involvement of MAP kinase cascades in Smad7 transcriptional regulation.
    Uchida K, Suzuki H, Ohashi T, Nitta K, Yumura W, Nihei H.
    Biochem Biophys Res Commun; 2001 Nov 30; 289(2):376-81. PubMed ID: 11716483
    [Abstract] [Full Text] [Related]

  • 38. Inactivation of smad-transforming growth factor beta signaling by Ca(2+)-calmodulin-dependent protein kinase II.
    Wicks SJ, Lui S, Abdel-Wahab N, Mason RM, Chantry A.
    Mol Cell Biol; 2000 Nov 30; 20(21):8103-11. PubMed ID: 11027280
    [Abstract] [Full Text] [Related]

  • 39. Advanced glycation end products activate Smad signaling via TGF-beta-dependent and independent mechanisms: implications for diabetic renal and vascular disease.
    Li JH, Huang XR, Zhu HJ, Oldfield M, Cooper M, Truong LD, Johnson RJ, Lan HY.
    FASEB J; 2004 Jan 30; 18(1):176-8. PubMed ID: 12709399
    [Abstract] [Full Text] [Related]

  • 40. Transforming growth factor-beta-induced mobilization of actin cytoskeleton requires signaling by small GTPases Cdc42 and RhoA.
    Edlund S, Landström M, Heldin CH, Aspenström P.
    Mol Biol Cell; 2002 Mar 30; 13(3):902-14. PubMed ID: 11907271
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.